Inhibitors of CD40-TRAF6 interaction

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9750717
SERIAL NO

15019581

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharmaceutical compositions comprising these compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHENGESCHWISTER-SCHOLL-PLATZ 1 MUNCHEN 80539

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lutgens, Esther Munich, DE 2 1
Nicolaes, Gerry Sint Geertruid, NL 2 1
Weber, Christian Munich, DE 99 1252

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00